Induction chemotherapy before surgery for unresectable head and neck cancer

Ngā tūemi rite

• Induction chemotherapy before surgery for unresectable head and neck cancer
  mā: H. Schmaltz, me ētahi atu.
  I whakaputaina: (2016-03-01)
• Induction chemotherapy with paclitaxel, carboplatin, and cetuximab (PCE) followed by chemoradiotherapy for unresectable locoregional recurrence after curative surgery in patients with squamous cell carcinoma of the head and neck
  mā: Masanobu Sato, me ētahi atu.
  I whakaputaina: (2024-07-01)
• Low-dose nivolumab plus induction chemotherapy for locally advanced or unresectable head and neck cancer is associated with high response rates and conversion to definitive therapy
  mā: Josh Thomas Georgy, me ētahi atu.
  I whakaputaina: (2025-10-01)
• A multicenter phase II trial of paclitaxel, carboplatin, and cetuximab followed by chemoradiotherapy in patients with unresectable locally advanced squamous cell carcinoma of the head and neck
  mā: Tomohiro Enokida, me ētahi atu.
  I whakaputaina: (2020-03-01)
• The role of induction chemotherapy followed by surgery in unresectable stage IVb laryngeal and hypopharyngeal cancers: a case series
  mā: Pichit Sittitrai, me ētahi atu.
  I whakaputaina: (2018-10-01)